Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Obesity Prevents Injections from Reaching Muscle

29.11.2005


Women may not be getting the most out of vaccines and other injections, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).



"Our study has demonstrated that a majority of people, especially women, are not getting the proper dosage from injections to the buttocks," said lead author Victoria O. Chan, M.B., registrar in the clinical medicine department of The Adelaide and Meath Hospital in Dublin, Ireland.

"There is no question that obesity is the underlying cause," Dr. Chan said. "We have identified a new problem related, in part, to the increasing amount of fat in patients’ buttocks."


Many medications are administered through injections into the muscles of the buttocks, including painkillers, vaccines, contraceptives and anti-nausea drugs. The upper, outer quadrant of the buttock is the preferred site for intramuscular injections, because there are relatively few major blood vessels, nerves and bones in this region that could be damaged by the needle. Yet the rich supply of microscopic blood vessels in muscle speeds drug absorption into the system.

Intramuscular injections are a common alternative when patients cannot swallow oral medications, are fasting for a procedure or have a metabolic disorder that inhibits the absorption of orally ingested medication. The use of intramuscular injections has increased over the past 10 years, and new medications have been developed for delivery in this way. However, Dr. Chan’s research has demonstrated a majority of these injections are largely ineffective.

"Our study has shown that 68 percent of intramuscular injections do not reach the muscles of the buttock," Dr. Chan said. "The amount of fat tissue overlying the muscles exceeds the length of the needles commonly used for these injections."

Pharmaceutical companies design medications so that the proper dosage is absorbed into the blood stream from the muscle. Because fat tissue has significantly fewer blood vessels relative to muscle, less of the medication is absorbed into the blood stream and delivered to the appropriate part of the body. "This results in the patient either not receiving the maximum benefit of the drug or receiving no benefit at all, because the drug levels are insufficient to have any effect," Dr. Chan said.

Furthermore, if the medication is not absorbed into the blood stream, it remains in the fatty tissue where it can cause local infection and irritation.

Dr. Chan and colleagues recruited 50 patients scheduled for computed tomography (CT) exams of the abdomen or pelvis. The patient group was equally divided among men and women, ranging from 21 to 87 years old.

Prior to the CT exams, patients were given intramuscular injections with the addition of a small air bubble into the upper quadrant of the buttocks using a standard-size needle. The researchers analyzed the CT images to determine the location of the air bubble and also measured body mass index, distance to injection site and thickness of fat and muscle.

The overall success rate of the injections was 32 percent. The success rate among men was 56 percent, while the success rate among women was only 8 percent, meaning 23 of 25 women did not receive injections into the muscle. Compared to men, women typically have a higher amount of fat in their buttocks. Dr. Chan proposes that a longer needle length is required to increase the success rate of intramuscular injections. "The more fat tissue there is in the buttock, the less likely the needle will reach the muscles underneath that fat," Dr. Chan said.

Co-authors are Jane Colville, M.B., Orla Buckley, M.B., Samuel Hamilton, M.B., Thara Persaud, M.B., and William Torreggiani, M.B.

Maureen Morley | EurekAlert!
Further information:
http://www.rsna.org

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>